Home > News > Altair Nanotechnologies to Present at the Wall Street Analyst Forum
February 25th, 2004
Altair Nanotechnologies to Present at the Wall Street Analyst Forum
Altair Nanotechnologies Inc. announced today that its President, Dr. Rudi Moerck, will be presenting to members of the financial community at the Wall Street Analyst Forum's Pharmaceutical Conference in New York City on March 1, 2004. Dr. Moerck will provide an overview of Altair Nanotechnologies' technology platform along with an in depth discussion and update of the company's patent-pending pharmaceutical, RenaZorb™. Additionally, Dr. Moerck will discuss the company's new nano-based drug delivery system that may possess properties that reduce the potential for the abuse of narcotics.
Park Systems Announces Outsourced Analytical Services Including AFM Surface Imaging, Data Analysis and Interpretation September 30th, 2014
Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014
New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014
Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014